CAPTRUST Financial Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
CAPTRUST Financial Advisors's IRWD Position: Q2 2026 in Review
CAPTRUST Financial Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 4.3% in Q2 2026, selling an estimated $12.4K and leaving 71,706 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #2591.
CAPTRUST Financial Advisors first reported a position in IRWD in Q4 2020 and has held it in 17 quarters since. The position peaked at $340K in Q4 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- CAPTRUST Financial Advisors held 71,706 shares of Ironwood Pharmaceuticals worth $302K as of Q2 2026.
- CAPTRUST Financial Advisors sold 3,224 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $12.4K.
- Ironwood Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2591 holding.
- CAPTRUST Financial Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 17 quarters since.
- CAPTRUST Financial Advisors's Ironwood Pharmaceuticals position peaked at $340K in Q4 2023.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.